The latest rounds of funding have proved successful with grants totalling more than £2.1 million awarded to scientists at The Pirbright Institute for research on virus and host characteristics. These studies will inform vaccine design and disease control for diseases that have a significant impact on animal and human health.
Recent funding awards include:
- Toby Tuthill – £629,854 from the MRC: Human rhinovirus VP4: A membrane pore-forming capsid protein and conserved target for broadly neutralising antibodies
- Andrew Broadbent, in collaboration with researchers in the USA and Holly Shelton as Co-Investigator – £595,339 from the BBSRC Ecology and Evolution of Infectious Diseases programme (EEID): Evaluating how the immune status of a flock affects the duration of disease, transmission parameters and evolution of avian influenza viruses
- Shahriar Behboudi – £484,110 from the BBSRC: Dissecting the role of virus-specific T cells in providing protection against Marek’s Disease Virus
- Andrew Broadbent – £444,164 from the BBSRC: Antigenic characterisation of diverse strains of infectious bursal disease virus to improve vaccination strategies and vaccine design
In addition to his grant awards Andrew Broadbent is also one of two Pirbright scientists that have been named among the twelve shortlisted finalists for the 2019 BBSRC Innovator of the Year competition.
The Innovator of the Year 2019 will be named at the Science Museum in London on 15 May 2019.